
Keywords: میکرو کامپوزیت; API; active pharmaceutical ingredient; Cmax; maximum plasma concentration; CQA; critical quality attribute; CPP; critical process parameter; EMA; European Medicines Agency; FDA; U.S. Food and Drug Administration; FPF; fine particle fraction; ICH; Internat